BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2364384)

  • 1. Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
    Perez-Soler R; Lopez-Berestein G; Lautersztain J; al-Baker S; Francis K; Macias-Kiger D; Raber MN; Khokhar AR
    Cancer Res; 1990 Jul; 50(14):4254-9. PubMed ID: 2364384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of toxicosis of liposome-encapsulated cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) in clinically normal cats.
    Fox LE; Toshach K; Calderwood-Mays M; Khokhar AR; Kubilis P; Perez-Soler R; MacEwen EG
    Am J Vet Res; 1999 Feb; 60(2):257-63. PubMed ID: 10048562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles.
    Perez-Soler R; Yang LY; Drewinko B; Lauterzstain J; Khokhar AR
    Cancer Res; 1988 Aug; 48(16):4509-12. PubMed ID: 3396003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R; Khokhar AR
    Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use.
    Perez-Soler R; Francis K; al-Baker S; Pilkiewicz F; Khokhar AR
    J Microencapsul; 1994; 11(1):41-54. PubMed ID: 8138874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
    Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
    J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Lopez-Berestein G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved antitumor activity of cis-Bis-neodecanoato-trans-R,R-1,2- diaminocyclohexaneplatinum (II) entrapped in long-circulating liposomes.
    Li S; Khokhar AR; Perez-Soler R; Huang L
    Oncol Res; 1995; 7(12):611-7. PubMed ID: 8704278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
    Sasaki Y; Amano T; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Kojima A; Saijo N
    Cancer Res; 1991 Mar; 51(5):1472-7. PubMed ID: 1997185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and anti-tumor activity of hydrophobic diammine and diaminocyclohexane platinum complexes entrapped in multilamellar vesicles.
    Khokhar AR; Al-Baker S; Perez-Soler R
    Anticancer Drug Des; 1988 Dec; 3(3):177-84. PubMed ID: 3207465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes.
    Lautersztain J; Perez-Soler R; Turpin J; Khokhar AR; Siddik ZH; Schmidt K; Lopez-Berestein G
    Cancer Res; 1988 Mar; 48(5):1300-6. PubMed ID: 3342409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
    Perez-Soler R; Lautersztain J; Stephens LC; Wright K; Khokhar AR
    Cancer Chemother Pharmacol; 1989; 24(1):1-8. PubMed ID: 2720887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Vadiei K; Siddik ZH; Khokhar AR; al-Baker S; Sampedro F; Perez-Soler R
    Cancer Chemother Pharmacol; 1992; 30(5):365-9. PubMed ID: 1505075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of JM9 in advanced ovarian cancer: a phase I-II trial.
    Bramwell VH; Crowther D; O'Malley S; Swindell R; Johnson R; Cooper EH; Thatcher N; Howell A
    Cancer Treat Rep; 1985 Apr; 69(4):409-16. PubMed ID: 3995511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
    Verschraegen CF; Kumagai S; Davidson R; Feig B; Mansfield P; Lee SJ; Maclean DS; Hu W; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):549-55. PubMed ID: 14513369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes.
    Khokhar AR; al-Baker S; Krakoff IH; Perez-Soler R
    Cancer Chemother Pharmacol; 1989; 23(4):219-24. PubMed ID: 2647311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
    Khokhar AR; Wright K; Siddik ZH; Perez-Soler R
    Cancer Chemother Pharmacol; 1988; 22(3):223-7. PubMed ID: 3409456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.